Thank you to our Co-Chairs, Steering Committee, speakers and panelists for your time, guidance, enthusiasm, and research.
Thank you to our wonderful audience!
- 825 registrants
- 43 countries from across the globe
- 39 U.S. states
We want to convey our sincere appreciation to our sponsors for making #KCRS20 possible. The support of companies large and small working to make new treatments available brings true hope for patients. Thank you to our industry research partners!
If you did not have time to visit the #KCRS20 Sponsors during the meeting, we hope you will visit their virtual exhibits, where they’ve provided many free resources and downloads for doctors.
We value your opinions, feedback and constructive ideas. Please take a few moments to answer our short survey or share your thoughts with us directly by e-mail here.
Until next year, warmest regards,
Susan Poteat, KidneyCAN Medical Science Liaison
Bryan Lewis, KidneyCAN President
#KCRS20 Welcome & Opening Remarks
Session One Discussion
Session Two Discussion
Session Three Discussion
Session Four Discussion
Ram Srinivasan, NIH
Elizabeth Henske, Brigham Women’s Hospital
Mehdi Mollapour, SUNY Upstate Medical Center
Gabriel Malouf, Institut de Cancérologie de Strasbourg
Jim Geller, Cincinnati Children’s Hospital
Roberto Pili, University at Buffalo
Pavlos Msaouel, MD Anderson Cancer Center
Stephane Oudard, Hôpital Européen Georges Pompidou
Brian Shuch, University of California Los Angeles
The second annual Kidney Cancer Research Summit is made possible through the generous contributions of our sponsors:
The Kidney Cancer Research Summit is also funded by KidneyCAN's grassroots supporters, a nationwide network of kidney cancer patients, caregivers, and family members who are committed to finding a cure.
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program).